001     277739
005     20240918103834.0
024 7 _ |a 10.3390/cancers15133313
|2 doi
024 7 _ |a pmid:37444426
|2 pmid
024 7 _ |a pmc:PMC10340689
|2 pmc
024 7 _ |a altmetric:151042080
|2 altmetric
037 _ _ |a DKFZ-2023-01456
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Figlioli, Gisella
|b 0
245 _ _ |a Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
260 _ _ |a Basel
|c 2023
|b MDPI
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726648692_16238
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a FANCM germline protein truncating variants (PTVs) are moderate-risk factors for ER-negative breast cancer. We previously described the spectrum of FANCM PTVs in 114 European breast cancer cases. In the present, larger cohort, we report the spectrum and frequency of four common and 62 rare FANCM PTVs found in 274 carriers detected among 44,803 breast cancer cases. We confirmed that p.Gln1701* was the most common PTV in Northern Europe with lower frequencies in Southern Europe. In contrast, p.Gly1906Alafs*12 was the most common PTV in Southern Europe with decreasing frequencies in Central and Northern Europe. We verified that p.Arg658* was prevalent in Central Europe and had highest frequencies in Eastern Europe. We also confirmed that the fourth most common PTV, p.Gln498Thrfs*7, might be a founder variant from Lithuania. Based on the frequency distribution of the carriers of rare PTVs, we showed that the FANCM PTVs spectra in Southwestern and Central Europe were much more heterogeneous than those from Northeastern Europe. These findings will inform the development of more efficient FANCM genetic testing strategies for breast cancer cases from specific European populations.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a FANCM PTVs spectrum
|2 Other
650 _ 7 |a PTVs
|2 Other
650 _ 7 |a breast cancer predisposition
|2 Other
650 _ 7 |a breast cancer risk factors
|2 Other
650 _ 7 |a protein truncating variants
|2 Other
700 1 _ |a Billaud, Amandine
|b 1
700 1 _ |a Wang, Qin
|b 2
700 1 _ |a Bolla, Manjeet K
|b 3
700 1 _ |a Dennis, Joe
|0 0000-0003-4591-1214
|b 4
700 1 _ |a Lush, Michael
|b 5
700 1 _ |a Kvist, Anders
|0 0000-0002-1358-0695
|b 6
700 1 _ |a Adank, Muriel A
|b 7
700 1 _ |a Ahearn, Thomas U
|b 8
700 1 _ |a Antonenkova, Natalia N
|b 9
700 1 _ |a Auvinen, Päivi
|b 10
700 1 _ |a Behrens, Sabine
|0 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
|b 11
|u dkfz
700 1 _ |a Bermisheva, Marina
|b 12
700 1 _ |a Bogdanova, Natalia V
|0 0000-0002-9736-4593
|b 13
700 1 _ |a Bojesen, Stig E
|b 14
700 1 _ |a Bonanni, Bernardo
|0 0000-0003-3589-2128
|b 15
700 1 _ |a Brüning, Thomas
|b 16
700 1 _ |a Camp, Nicola J
|0 0000-0002-4788-1998
|b 17
700 1 _ |a Campbell, Archie
|0 0000-0003-0198-5078
|b 18
700 1 _ |a Castelao, Jose E
|b 19
700 1 _ |a Cessna, Melissa H
|b 20
700 1 _ |a Nbcs Collaborators
|b 21
700 1 _ |a Czene, Kamila
|b 22
700 1 _ |a Devilee, Peter
|0 0000-0002-8023-2009
|b 23
700 1 _ |a Dörk, Thilo
|0 0000-0002-9458-0282
|b 24
700 1 _ |a Eriksson, Mikael
|0 0000-0001-8135-4270
|b 25
700 1 _ |a Fasching, Peter A
|0 0000-0003-4885-8471
|b 26
700 1 _ |a Flyger, Henrik
|b 27
700 1 _ |a Gabrielson, Marike
|b 28
700 1 _ |a Gago-Dominguez, Manuela
|b 29
700 1 _ |a García-Closas, Montserrat
|b 30
700 1 _ |a Glendon, Gord
|b 31
700 1 _ |a Gómez Garcia, Encarna B
|b 32
700 1 _ |a González-Neira, Anna
|0 0000-0002-5421-2020
|b 33
700 1 _ |a Grassmann, Felix
|b 34
700 1 _ |a Guénel, Pascal
|b 35
700 1 _ |a Hahnen, Eric
|b 36
700 1 _ |a Hamann, Ute
|0 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
|b 37
|u dkfz
700 1 _ |a Hillemanns, Peter
|0 0000-0001-9829-3531
|b 38
700 1 _ |a Hooning, Maartje J
|b 39
700 1 _ |a Hoppe, Reiner
|b 40
700 1 _ |a Howell, Anthony
|b 41
700 1 _ |a Humphreys, Keith
|0 0000-0002-7458-8252
|b 42
700 1 _ |a kConFab Investigators
|b 43
700 1 _ |a Jakubowska, Anna
|0 0000-0002-5650-0501
|b 44
700 1 _ |a Khusnutdinova, Elza K
|b 45
700 1 _ |a Kristensen, Vessela N
|b 46
700 1 _ |a Lindblom, Annika
|b 47
700 1 _ |a Loizidou, Maria A
|0 0000-0003-4503-7758
|b 48
700 1 _ |a Lubiński, Jan
|b 49
700 1 _ |a Mannermaa, Arto
|b 50
700 1 _ |a Maurer, Tabea
|b 51
700 1 _ |a Mavroudis, Dimitrios
|b 52
700 1 _ |a Newman, William G
|0 0000-0002-6382-4678
|b 53
700 1 _ |a Obi, Nadia
|0 0000-0002-0903-9142
|b 54
700 1 _ |a Panayiotidis, Mihalis I
|0 0000-0002-1450-3552
|b 55
700 1 _ |a Radice, Paolo
|0 0000-0001-6298-4111
|b 56
700 1 _ |a Rashid, Muhammad U
|0 0000-0002-7684-3122
|b 57
700 1 _ |a Rhenius, Valerie
|b 58
700 1 _ |a Ruebner, Matthias
|b 59
700 1 _ |a Saloustros, Emmanouil
|0 0000-0002-0485-0120
|b 60
700 1 _ |a Sawyer, Elinor J
|b 61
700 1 _ |a Schmidt, Marjanka K
|0 0000-0002-2228-429X
|b 62
700 1 _ |a Schmutzler, Rita K
|b 63
700 1 _ |a Shah, Mitul
|b 64
700 1 _ |a Southey, Melissa C
|b 65
700 1 _ |a Tomlinson, Ian
|b 66
700 1 _ |a Truong, Thérèse
|b 67
700 1 _ |a van Veen, Elke M
|0 0000-0001-8618-2332
|b 68
700 1 _ |a Wendt, Camilla
|b 69
700 1 _ |a Yang, Xiaohong R
|b 70
700 1 _ |a Michailidou, Kyriaki
|0 0000-0001-7065-1237
|b 71
700 1 _ |a Dunning, Alison M
|b 72
700 1 _ |a Pharoah, Paul D P
|0 0000-0001-8494-732X
|b 73
700 1 _ |a Easton, Douglas F
|b 74
700 1 _ |a Andrulis, Irene L
|0 0000-0002-4226-6435
|b 75
700 1 _ |a Evans, D Gareth
|0 0000-0002-8482-5784
|b 76
700 1 _ |a Hollestelle, Antoinette
|0 0000-0003-1166-1966
|b 77
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 78
|u dkfz
700 1 _ |a Milne, Roger L
|b 79
700 1 _ |a Peterlongo, Paolo
|0 0000-0001-6951-6855
|b 80
773 _ _ |a 10.3390/cancers15133313
|g Vol. 15, no. 13, p. 3313 -
|0 PERI:(DE-600)2527080-1
|n 13
|p 3313
|t Cancers
|v 15
|y 2023
|x 2072-6694
909 C O |p VDB
|o oai:inrepo02.dkfz.de:277739
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 37
|6 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 78
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2023
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2022-01-24T07:56:58Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-30
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2022-11-30
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2022-11-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCERS : 2022
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-07-31T16:07:06Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-07-31T16:07:06Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-07-31T16:07:06Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-26
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCERS : 2022
|d 2023-10-26
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)B072-20160331
|k B072
|l Molekulargenetik des Mammakarzinoms
|x 1
920 1 _ |0 I:(DE-He78)B070-20160331
|k B070
|l B070 Funktionelle Genomanalyse
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)B072-20160331
980 _ _ |a I:(DE-He78)B070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21